Answer questions and earn CME/CNE Pancreatic cancer is currently one of the deadliest of
the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and …

Substantial progress has been made in our understanding of the biology of pancreatic
cancer, and advances in patients' management have also taken place. Evidence is …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient
survival. Toward understanding the underlying molecular alterations that drive PDAC …

Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank
fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer …

Background Serum carbohydrate antigen (CA 19-9) is the most common tumor marker
assessed in pancreatic cancer patients; nevertheless few articles have comprehensively …

Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United
States, with over 38000 deaths in 2013. The opportunity to detect pancreatic cancer while it …

Markers are needed to facilitate early detection of pancreatic ductal adenocarcinoma
(PDAC), which is often diagnosed too late for effective therapy. Starting with a PDAC cell …

The GeneMANIA Cytoscape plugin brings fast gene function prediction capabilities to the
desktop. GeneMANIA identifies the most related genes to a query gene set using a guilt-by …

Background We describe demographic features, treatments and clinical outcomes in the
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) COVID …

Pancreatic carcinoma (PC) is a lethal cancer. Gut microbiota is associated with some risk
factors of PC, eg obesity and types II diabetes. However, the specific gut microbial profile in …